Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| COMIRNATY OMICRON XBB.1.5 | BioNTech Manufacturing GmbH | Cancelled Post Market | Oct 24, 2023 | Cancelled Po... |
| FLUCONAZOLE | sivem pharmaceuticals ulc | Marketed | Oct 24, 2023 | Marketed |
| TREKSAFE | zhejiangh hongyu medical commodity co ltd | Marketed | Oct 24, 2023 | Marketed |
| FLECAINIDE | sanis health inc | Marketed | Oct 24, 2023 | Marketed |
| ANESKETIN | Eurovet Animal Health B.V. | Marketed | Oct 23, 2023 | Marketed |
| MOUNJARO | eli lilly canada inc | Marketed | Oct 23, 2023 | Marketed |
| COMIRNATY | BioNTech Manufacturing GmbH | Marketed | Oct 23, 2023 | Marketed |
| IMJUDO | astrazeneca canada inc | Marketed | Oct 23, 2023 | Marketed |
| MOUNJARO | eli lilly canada inc | Marketed | Oct 23, 2023 | Marketed |
| MOUNJARO | eli lilly canada inc | Marketed | Oct 23, 2023 | Marketed |
| MOUNJARO | eli lilly canada inc | Marketed | Oct 23, 2023 | Marketed |
| LEVOFLOXACIN IN 5% DEXTROSE INJECTION | hikma canada limited | Marketed | Oct 23, 2023 | Marketed |
| MOUNJARO | eli lilly canada inc | Marketed | Oct 23, 2023 | Marketed |
| MOUNJARO | eli lilly canada inc | Marketed | Oct 23, 2023 | Marketed |
| MINT-BETAHISTINE | mint pharmaceuticals inc | Marketed | Oct 20, 2023 | Marketed |
| TECVAYLI | Janssen Inc | Marketed | Oct 20, 2023 | Marketed |
| JAMP TOFACITINIB | Jamp Pharma Corporation | Marketed | Oct 20, 2023 | Marketed |
| MINT-BETAHISTINE | mint pharmaceuticals inc | Marketed | Oct 20, 2023 | Marketed |
| TECVAYLI | Janssen Inc | Marketed | Oct 20, 2023 | Marketed |
| NRA-DONEPEZIL | nora pharma inc | Marketed | Oct 16, 2023 | Marketed |
